116 related articles for article (PubMed ID: 19686517)
1. Estimating the burden of disease attributable to illicit drug use and mental disorders: what is 'Global Burden of Disease 2005' and why does it matter?
Degenhardt L; Whiteford H; Hall W; Vos T
Addiction; 2009 Sep; 104(9):1466-71. PubMed ID: 19686517
[TBL] [Abstract][Full Text] [Related]
2. How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?
Whiteford HA; Ferrari AJ; Baxter AJ; Charlson FJ; Degenhardt L
Curr Opin Psychiatry; 2013 Jul; 26(4):376-83. PubMed ID: 23689547
[TBL] [Abstract][Full Text] [Related]
3. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease?
Degenhardt L; Whiteford H; Hall WD
Drug Alcohol Rev; 2014 Jan; 33(1):4-12. PubMed ID: 24251757
[TBL] [Abstract][Full Text] [Related]
4. Global burden of disease from alcohol, illicit drugs and tobacco.
Rehm J; Taylor B; Room R
Drug Alcohol Rev; 2006 Nov; 25(6):503-13. PubMed ID: 17132570
[TBL] [Abstract][Full Text] [Related]
5. Global "burden of disease"-study for psychiatric disorders.
Ustün TB; Chisholm D
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S7-11. PubMed ID: 11533901
[TBL] [Abstract][Full Text] [Related]
6. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use.
Chisholm D; Doran C; Shibuya K; Rehm J
Drug Alcohol Rev; 2006 Nov; 25(6):553-65. PubMed ID: 17132573
[TBL] [Abstract][Full Text] [Related]
7. Global burden of disease (GBD) for hepatitis C.
Global Burden Of Hepatitis C Working Group
J Clin Pharmacol; 2004 Jan; 44(1):20-9. PubMed ID: 14681338
[TBL] [Abstract][Full Text] [Related]
8. Costs of nine common mental disorders: implications for curative and preventive psychiatry.
Smit F; Cuijpers P; Oostenbrink J; Batelaan N; de Graaf R; Beekman A
J Ment Health Policy Econ; 2006 Dec; 9(4):193-200. PubMed ID: 17200596
[TBL] [Abstract][Full Text] [Related]
9. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs.
Jané-Llopis E; Matytsina I
Drug Alcohol Rev; 2006 Nov; 25(6):515-36. PubMed ID: 17132571
[TBL] [Abstract][Full Text] [Related]
10. The contribution of occupational risks to the global burden of disease: summary and next steps.
Fingerhut M; Nelson DI; Driscoll T; Concha-Barrientos M; Steenland K; Punnett L; Prüss-Ustün A; Leigh J; Corvalan C; Eijkemans G; Takala J
Med Lav; 2006; 97(2):313-21. PubMed ID: 17017364
[TBL] [Abstract][Full Text] [Related]
11. The burden of mental disorders: a comparison of methods between the Australian burden of disease studies and the Global Burden of Disease study.
Vos T; Mathers CD
Bull World Health Organ; 2000; 78(4):427-38. PubMed ID: 10885161
[TBL] [Abstract][Full Text] [Related]
12. Child and adolescent mental disorders: the magnitude of the problem across the globe.
Belfer ML
J Child Psychol Psychiatry; 2008 Mar; 49(3):226-36. PubMed ID: 18221350
[TBL] [Abstract][Full Text] [Related]
13. Patterns of illicit drug use of prisoners in police custody in London, UK.
Payne-James JJ; Wall IJ; Bailey C
J Clin Forensic Med; 2005 Aug; 12(4):196-8. PubMed ID: 15950514
[TBL] [Abstract][Full Text] [Related]
14. Psychoactive drug abuse in older adults.
Simoni-Wastila L; Yang HK
Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
[TBL] [Abstract][Full Text] [Related]
15. Estimating the global burden of thalassogenic diseases: human infectious diseases caused by wastewater pollution of the marine environment.
Shuval H
J Water Health; 2003 Jun; 1(2):53-64. PubMed ID: 15382734
[TBL] [Abstract][Full Text] [Related]
16. Screening psychiatric patients for illicit drug use disorders and problems.
Tiet QQ; Finney JW; Moos RH
Clin Psychol Rev; 2008 Apr; 28(4):578-91. PubMed ID: 17900773
[TBL] [Abstract][Full Text] [Related]
17. Estimating the global disease burden due to ultraviolet radiation exposure.
Lucas RM; McMichael AJ; Armstrong BK; Smith WT
Int J Epidemiol; 2008 Jun; 37(3):654-67. PubMed ID: 18276627
[TBL] [Abstract][Full Text] [Related]
18. [Global mental health].
Kastrup MC; Ramos AB
Ugeskr Laeger; 2006 Sep; 168(36):3030-2. PubMed ID: 16999898
[TBL] [Abstract][Full Text] [Related]
19. [Psychoactive drug use in a declared non-addicted control sample and comorbidity. Results of a study in 860 French-speaking subjects].
Nezelof S; Taccoen Y; Corcos M; Girardon N; Perez-Diaz F; Bizouard P; Venisse JL; Halfon O; Loas G; Lang F; Flament M; Jeammet P
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS18-25. PubMed ID: 11435991
[TBL] [Abstract][Full Text] [Related]
20. Resource utilisation for neuropsychiatric disorders in developing countries: a multinational Delphi consensus study.
Ferri C; Chisholm D; Van Ommeren M; Prince M
Soc Psychiatry Psychiatr Epidemiol; 2004 Mar; 39(3):218-27. PubMed ID: 14999455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
